NCT04870671View on ClinicalTrials.gov

Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
HIV/AIDSAdherence, MedicationDrug Use
Interventions
DRUG

Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)

Women will take 1 pill orally according the dosing regimen of the arm to which they are assigned

Trial Locations (1)

23507

Clinical Research Center, Eastern Virginia Medical School, Norfolk

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Eastern Virginia Medical School

OTHER

NCT04870671 - Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor | Biotech Hunter | Biotech Hunter